| Company/Division name | Gilead Sciences Inc. |
| Parent company | Gilead Sciences, Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 325 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2030 |
| Capital investment ($): | 3200 |
| City reshored to: | Foster City |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Higher productivity, Impact on domestic economy, Infrastructure, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market, Skilled workforce availability/training |
